Continuing Education from Anivive 

Anivive is now offering RACE-approved CE for veterinarians and veterinary technicians.

New Primary Care Treatment Protocols for Lymphoma in Dogs

Be ready when that next lymphoma case enters your exam room.

The options for canine lymphoma patients have never been better, and primary care veterinary teams can now provide a lot more than prednisone. Learn what you can do for lymphoma patients before they ever see a specialist, how to communicate with clients about cancer, and how a new class of drugs is changing the game.


• Recommended diagnostics that can inform tailored treatment protocols

• An oncologist’s advice for talking to clients about a cancer diagnosis and treatment options

• When and how to start treating lymphoma patients in your practice

• What to do for patients waiting to see a specialist

• How the new SINE class of drugs work

*This program is pending approval for 1 hour of CE credit in the jurisdictions that recognize RACE approval.

Verdinexor: A New Oral Treatment Option for Canine Lymphoma

Join Lone Star Veterinary Academy and accomplished Veterinary Oncologist, Avenelle Turner, DVM, DACVIM (Oncology), on July 25 to discuss a new clinical breakthrough in therapy for canine lymphoma! In this one-hour session, we will review the diagnosis, prognosis, and treatment of lymphoma, before diving into an eye-opening discussion on a novel class of chemotherapeutic drugs: SINE Inhibitors. We’ll study the mechanism of action, efficacy, adverse effects, and clinical utility for your practice. Invite your whole team to listen live and learn about this promising new option for treating canine lymphoma.


  • Review the diagnosis, prognosis, and current treatment options for canine lymphoma
  • Study clinical efficacy and safety data for an FDA conditionally approved novel therapy: LAVERDIA-CA1 (verdinexor).
  • Understand how LAVERDIA-CA1 (verdinexor) could be implemented in your practice.


  • 1 hour CE
  • Complete digital course notes delivered by email
  • Webinar log-in information provided by email
  • Access to session recordings for 30 days following completion of workshop

This program has been approved for 1.0 hour of continuing education credit in jurisdictions that recognize RACE approval.

Diagnosing and Treating Canine Lymphoma in Primary Care Clinics: New best practices from a veterinary oncologist’s perspective

Wish you could do more for your canine lymphoma patients? Good news: Best practices for diagnosing and treating canine lymphoma are moving forward at a rapid pace, and general practitioners can do more than ever to help dogs with lymphoma. 

Join veterinary oncologist Dr. Craig Clifford, director of clinical studies at Hope Veterinary Specialists/BluePearl Malvern, for this 1-hour CE session to learn about a novel treatment option, LAVERDIA-CA1, and how it may fit in at your clinic. We’ll also review the latest techniques for staging and grading lymphoma—and share tips for collaborating with your local specialist on a treatment plan.

LAVERDIA-CA1 Educational Sessions

Note: The following educational and training sessions have been previously recorded and do not count for any continuing education (CE) credits. They are informational recordings from previous presentations that provide valuable information about diagnosing lymphoma and incorporating LAVERDIA-CA1 into your practice.

You Diagnosed Lymphoma, Now What?

The diagnosis and treatment of canine lymphoma is moving forward at an increasingly rapid pace. In this session, you will:

  • Learn how to diagnose, stage, and grade canine lymphoma

  • Learn the importance of phenotyping

  • Explore the role of chemotherapy and protocol selection in naïve and relapse cases

  • Review new treatment options


The following education sessions, presented by Dan Dreyfuss, DVM, Veterinary Technical Services Manager at Anivive, were intended for veterinary professionals. Attendees learned more about LAVERDIA-CA1, the first FDA conditionally approved oral tablet to treat lymphoma in dogs. You can watch the recordings below.

May 6, 2021

10:00pm PT

May 14, 2021

12:30pm PT

May 26, 2021

5:00pm PT